Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 169

1.

Interferon-gamma inhibition of human thyrotropin receptor gene expression.

Nishikawa T, Yamashita S, Namba H, Usa T, Tominaga T, Kimura H, Izumi M, Nagataki S.

J Clin Endocrinol Metab. 1993 Oct;77(4):1084-9.

PMID:
8408457
2.
3.

Effects of ceramide and protein kinase C on the regulation of type I 5'-deiodinase in FRTL-5 rat thyroid cells.

Mori K, Stone S, Braverman LE, DeVito WJ.

Endocrinology. 1996 Nov;137(11):4994-9.

PMID:
8895373
4.
6.

Interferon-gamma inhibits thyrotropin-induced thyroidal peroxidase gene expression in cultured human thyrocytes.

Ashizawa K, Yamashita S, Nagayama Y, Kimura H, Hirayu H, Izumi M, Nagataki S.

J Clin Endocrinol Metab. 1989 Aug;69(2):475-7.

PMID:
2546966
7.
8.

Retinoic acid inhibits human thyroid peroxidase and thyroglobulin gene expression in cultured human thyrocytes.

Namba H, Yamashita S, Morita S, Villadolid MC, Kimura H, Yokoyama N, Izumi M, Ishikawa N, Ito K, Nagataki S.

J Endocrinol Invest. 1993 Feb;16(2):87-93.

PMID:
8463554
10.
11.

Effect of thyroid-stimulating hormone on cultured thyrocytes obtained from patients with Graves' disease and inhibitive effect by sodium iodide: a functional study.

Yamashita H, Noguchi S, Murakami N, Adachi M, Yasuoka Y, Wakiya S, Kitamura H.

Pathol Int. 1994 Dec;44(12):827-31.

PMID:
7866565
12.

Regulation of thyrotropin receptor gene expression in rat FRTL-5 thyroid cells.

Saji M, Akamizu T, Sanchez M, Obici S, Avvedimento E, Gottesman ME, Kohn LD.

Endocrinology. 1992 Jan;130(1):520-33.

PMID:
1309347
15.

Thyrotropin (TSH) receptor antibodies (TSHrAb) can inhibit TSH-mediated cyclic adenosine 3',5'- monophosphate production in thyroid cells by either blocking TSH binding or affecting a step subsequent to TSH binding.

Dallas JS, Cunningham SJ, Patibandla SA, Seetharamaiah GS, Morris JC, Tahara K, Kohn LD, Prabhakar BS.

Endocrinology. 1996 Aug;137(8):3329-39.

PMID:
8754759
16.

Increased expression of the Na+/I- symporter in cultured human thyroid cells exposed to thyrotropin and in Graves' thyroid tissue.

Saito T, Endo T, Kawaguchi A, Ikeda M, Nakazato M, Kogai T, Onaya T.

J Clin Endocrinol Metab. 1997 Oct;82(10):3331-6.

PMID:
9329364
17.

Iodide, cytokines and TSH-receptor expression in Graves' disease.

Schuppert F, Hiller W, Weinland G, Hoang-Vu C, von zur Mühlen A, Kohn LD.

Exp Clin Endocrinol Diabetes. 1996;104 Suppl 4:68-74.

PMID:
8981006
18.

p66Shc expression in proliferating thyroid cells is regulated by thyrotropin receptor signaling.

Park YJ, Kim TY, Lee SH, Kim H, Kim SW, Shong M, Yoon YK, Cho BY, Park DJ.

Endocrinology. 2005 May;146(5):2473-80. Epub 2005 Feb 10.

PMID:
15705774
19.

Modulation of Fas-mediated apoptosis of human thyroid epithelial cells by IgG from patients with Graves' disease (GD) and idiopathic myxoedema.

Kawakami A, Eguchi K, Matsuoka N, Tsuboi M, Urayama S, Kawabe Y, Tahara K, Ishikawa N, Ito K, Nagataki S.

Clin Exp Immunol. 1997 Dec;110(3):434-9.

20.

Monoclonal antibodies to the thyrotropin receptor raised by an autoantiidiotypic protocol and their relationship to monoclonal autoantibodies from Graves' patients.

Hill BL, Erlanger BF.

Endocrinology. 1988 Jun;122(6):2840-50. Erratum in: Endocrinology 1988 Sep;123(3):1525. Endocrinology 1988 Oct;123(4):2123.

PMID:
2453350

Supplemental Content

Support Center